UBS Group’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.89M Buy
+25,000
New +$1.78M ﹤0.01% 5026
2025
Q2
Sell
-9,700
Closed -$482K 10659
2025
Q1
$482K Buy
+9,700
New +$496K ﹤0.01% 5879
2023
Q4
Sell
-47,100
Closed -$2.91M 9720
2023
Q3
$2.91M Hold
47,100
﹤0.01% 3088
2023
Q2
$2.78M Buy
+47,100
New +$3M ﹤0.01% 3205
2022
Q2
Sell
-192,194
Closed -$20M 10724
2022
Q1
$20M Buy
+192,194
New +$15.9M 0.01% 1419

Other funds holding NTR

UBS Group's NTR Position: Q1 2026 in Review

UBS Group increased its Nutrien (NTR) stake by 1.4% in Q1 2026, buying an estimated $1.04M and bringing the position to 1,078,557 shares worth $81.4M. The position accounts for 0.01% of the portfolio, ranked #1209.

UBS Group first reported a position in NTR in Q1 2018 and has held it in 33 quarters since. The position peaked at $128M in Q1 2022. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • UBS Group held 1,078,557 shares of Nutrien worth $81.4M as of Q1 2026.
  • UBS Group bought 14,541 Nutrien shares in Q1 2026, an estimated $1.04M.
  • Nutrien made up 0.01% of UBS Group's portfolio in Q1 2026, its #1209 holding.
  • UBS Group first reported a position in Nutrien in Q1 2018 and has held it in 33 quarters since.
  • UBS Group's Nutrien position peaked at $128M in Q1 2022.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.